Does Green Tea Affect Postprandial Glucose, Insulin and Satiety in Healthy Subjects
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01086189 |
Recruitment Status :
Completed
First Posted : March 12, 2010
Last Update Posted : March 12, 2010
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Green tea consumption could lower the risk of type II diabetes, as suggested by epidemiological studies. There is also evidence from intervention studies that green tea can decrease blood glucose levels and contribute to weight loss.
The aim with this study is therefore to examine the postprandial effects of green tea on glycemic index, insulin levels and satiety in healthy individuals after the consumption of a meal.
Condition or disease |
---|
Diabetes Type 2 Obesity |
Study Type : | Observational |
Actual Enrollment : | 14 participants |
Observational Model: | Case-Crossover |
Time Perspective: | Cross-Sectional |
Study Start Date : | December 2009 |
Actual Study Completion Date : | February 2010 |

- Postprandial glucose and insulin
- Postprandial satiety

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Healthy subjects
Exclusion Criteria:
- Diabetes

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01086189
Sweden | |
Skane University Hospital | |
Malmo, Skane, Sweden, 205 02 |
ClinicalTrials.gov Identifier: | NCT01086189 |
Other Study ID Numbers: |
2009/66 |
First Posted: | March 12, 2010 Key Record Dates |
Last Update Posted: | March 12, 2010 |
Last Verified: | December 2009 |
Diabetes Mellitus, Type 2 Diabetes Mellitus Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |